Literature DB >> 16636814

Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns.

Ryszard Lauterbach1, Dorota Pawlik, Renata Radziszewska, Joanna Woźniak, Krzysztof Rytlewski.   

Abstract

OBJECTIVE: The aim of this prospective, observational study was to establish the prognostic values of plasma antithrombin III (ATIII) and protein C (PC) functional levels, determined in 150 neonates with suspected late-onset sepsis. OBSERVATIONS: Both the ATIII and PC concentrations were significantly lower in neonates with sepsis, either confirmed or not confirmed by blood culture, than data obtained in infants with excluded disease. The lowest values of plasma ATIII and PC were observed in neonates who had died in the course of sepsis. The differences between survivors and non-survivors were statistically significant (respectively, for ATIII P=0.003 and for PC P=0.00002). A highly statistically significant correlation (P=0.0016) between plasma PC functional level and risk of death was found in patients with sepsis. However, plasma ATIII concentration, evaluated in the same group of patients, did not correlate with the occurrence of death.
CONCLUSION: We concluded that the measurement of plasma ATIII and, especially, PC levels may facilitate the recognition of sepsis and, with respect to PC, may have a prognostic value. Plasma PC functional concentration below 10% might be the indication for supplementation of PC concentrate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636814     DOI: 10.1007/s00431-006-0139-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma.

Authors:  G Cvirn; S Gallistl; W Muntean
Journal:  Thromb Res       Date:  1999-02-15       Impact factor: 3.944

Review 2.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

Review 3.  Neonatal sepsis: a challenge in hemostaseology.

Authors:  W Kreuz; A Veldmann; D Fischer; R Schlösser; W R Volk; C E Ettingshausen
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

4.  Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.

Authors:  M Dreyfus; J F Magny; F Bridey; H P Schwarz; C Planché; M Dehan; G Tchernia
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

5.  Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.

Authors:  Ester D de Kleijn; Ronald de Groot; C Erik Hack; Paul G H Mulder; Werner Engl; Berta Moritz; Koen F M Joosten; Jan A Hazelzet
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

Review 6.  Protein C pathway in infants and children.

Authors:  Jari Petäjä; Marilyn J Manco-Johnson
Journal:  Semin Thromb Hemost       Date:  2003-08       Impact factor: 4.180

7.  Severe protein C deficiency predicts early death in severe sepsis.

Authors:  William L Macias; David R Nelson
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

8.  Treatment of purpura fulminans in meningococcemia with protein C concentrate.

Authors:  G E Rivard; M David; C Farrell; H P Schwarz
Journal:  J Pediatr       Date:  1995-04       Impact factor: 4.406

9.  Recombinant human activated protein C for severe sepsis in a neonate.

Authors:  Marcin Rawicz; Bozena Sitkowska; Iwona Rudzińska; Maria K Kornacka; Przemysław Bocheński
Journal:  Med Sci Monit       Date:  2002-11

10.  Severe neonatal protein C deficiency: prevalence and thrombotic risk.

Authors:  M J Manco-Johnson; T C Abshire; L J Jacobson; R A Marlar
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

View more
  11 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

Review 2.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 3.  Role of innate host defenses in susceptibility to early-onset neonatal sepsis.

Authors:  James L Wynn; Ofer Levy
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 4.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31

5.  COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis.

Authors:  Alessandra F Perna; Giovanna Capolongo; Francesco Trepiccione; Mariadelina Simeoni; Miriam Zacchia; Diego Ingrosso
Journal:  Kidney Blood Press Res       Date:  2020-05-25       Impact factor: 2.687

6.  Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis.

Authors:  Christian Niederwanger; Mirjam Bachler; Tobias Hell; Caroline Linhart; Andreas Entenmann; Agnes Balog; Katharina Auer; Petra Innerhofer
Journal:  Ann Intensive Care       Date:  2018-11-16       Impact factor: 6.925

7.  Response patterns of routinely measured inflammatory and coagulatory parameters in sepsis.

Authors:  Mirjam Bachler; Tobias Hell; Lukas Schausberger; Christine Schlömmer; Volker Schäfer; Marlies Liebensteiner; Katharina Schäffler; Bettina Schenk; Dietmar Fries; Petra Innerhofer; Christian Niederwanger
Journal:  PeerJ       Date:  2019-06-21       Impact factor: 2.984

8.  Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings.

Authors:  Thor A Wagner; Courtney A Gravett; Sara Healy; Viju Soma; Janna C Patterson; Michael G Gravett; Craig E Rubens
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

9.  Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.

Authors:  Qute Choi; Ki Ho Hong; Ji-Eun Kim; Hyun Kyung Kim
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

10.  Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study.

Authors:  Christian Niederwanger; Tobias Hell; Sophie Hofer; Christina Salvador; Miriam Michel; Bettina Schenk; Benedikt Treml; Mirjam Bachler
Journal:  PeerJ       Date:  2018-09-05       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.